IFSC
1.10.2021 13:32:06 CEST | Business Wire | Press release
At 2:30 pm Paris time on September 30, 2021, SHENZHEN FUTIAN FASHION INVESTMENT 2021 PARIS FORUM was successfully held in Paris, France with the support of Futian District People’s Government of Shenzhen Municipality, which showed the charm of Futian to the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211001005355/en/
The forum is not only a grand event for the development of the fashion industry in Futian District, but also another achievement of the exchanges between China and France in the field of fashion. With Shenzhen Futian Fashion Investment Promotion as the core, this forum will promote Futian's high-quality business environment, industrial foundation and industrial projects to the world. International institutions, fashion brands and international talents are warmly invited to Futian for development.
With the help of the international professional organization, Futian International Fashion Strategy Committee, and rely on the top fashion event of Paris Fashion Week to gather high-end international fashion resources. The event was actively participated by top fashion authority in the world, French government agencies, international luxury groups, and international fashion media. This event was strongly supported by Paris La Défense, GBD Innovation Club, DEFI La Mode de France, Federation de la Haute Couture de la Mode, Kering Group, Institut Français de la Mode, EnaMoMa by PSL, Comité Professionnel de Développement de l'Horlogerie, de la Bijouterie, de la Joaillerie, de l'Orfèvrerie et des Arts de la Table, , , Le Chinese Business Club, Who's Next (WSN) and other French institutions and international organizations. Mr. Pierre-Yves Guice, CEO of Paris La Défense, President of GBD Innovation Club, Mr. Pascal Morand, Executive President of Fédération de la Haute Couture et de la Mode, Head of Global Fashion and Design Department, top fashion authority in the world, Mr. Sébastien Vicente, Head of Art de Vivre Department of Business France, and other international guests attended this event. 150 Paris entrepreneurs, guests in the industry and international media also attended this event, and talked about innovation and development and win-win cooperation with representatives of Shenzhen Futian District, the most active and innovative CBD in China.
Hand in Hand Towards a Bright Future
Mr. Zhou Jiangtao, Acting District Mayor of Futian District People’s Government of Shenzhen Municipality said, Futian is seizing major historical opportunities such as the construction of Guangdong-Hong Kong-Macao Greater Bay Area and Shenzhen Pilot Demonstration Zone, highlighting the ‘three major industries’ of science and technology, finance, and fashion, and striving to build a central innovation zone, a central business district, and a central vitality zone.
Optimize the business environment and cultivate fertile ground for the international development of the fashion industry.
Shenzhen Futian CBD Comprehensive Development Index ranks among the top three in China. In 2020, it became an official member of the GBD Innovation Club.
FuTian–the New Power of International Fashion
Ms. Meng Man, Deputy District Mayor of Futian District People’s Government of Shenzhen Municipality and Vice President of IFSC, gave a keynote speech through a video, stating that "Futian will make every effort to build a cluster of fashion industry development with a core engine + multi-point support." Futian District is looking forward to working with international fashion companies, professional institutions, and talents around the world to" build a plateau of China's fashion industry and jointly open up a new territory for the world's fashion industry".
International Summit Forum brings together celebrities in the international fashion industry
At this event, two major thematic summit forums were held on "Innovative Development of GBD" and "Future Development of International Fashion Industry". A number of international fashion business executives participated in the exchange and discussed the development model of the city's core business districts and fashion industry and international innovation cooperation matters. The guests at the conference fully recognized Futian’s business planning and fashion development concepts, and expressed their willingness to develop in Futian.
Deepen international cooperation and create an "international designer alliance"
Explore a new mode of cooperation in the international fashion field
Futian is one of China's fashion industry centers, with more than 2,000 fashion companies and an industry scale of more than 120 billion yuan. It also has strong advantages in the fashion design industry. Among them, the high-end clothing and architectural decoration design industries are far ahead in China and well-known internationally. After the event, Ms. Dong Shan, Director of Futian District Culture, Radio, Television, Tourism and Sports Bureau of Shenzhen, and Executive Director of IFSC, said in a video interview with the media, Futian District constantly stimulates new momentum for the integration and development of the fashion industry, builds an international professional service industry cluster, and all-round grafting of international fashion resources, realizing the gathering of resources in the international fashion value chain, and building a “world-class bay area fashion center”.
In this event, International Fashion Strategy Committee of Futian District signed the “Letter of Intent on Paris Outstanding Designer Fashion Cooperation Project” with EnaMoMa by PSL, and established a formal international cooperation relationship between Shenzhen Futian and Paris in the field of fashion and design. Together the two parties would build a bridge for cooperation between a large number of outstanding international designers and various fashion brand enterprises, thereby building a healthy ecosystem of the international fashion industry.
As China's first urban and regional international fashion strategy executive agency, Futian International Fashion Strategy Committee has actively carried out international fashion industrialization exchanges and cooperation, attracting international resources to promote the joint work, deeply entering the international stage of the fashion industry, and fully displaying the international city image of Futian, Shenzhen. It is hoped that through series of promotion activities, exchanges between China and France and international influence of China’s fashion forces represented by Futian will be promoted, letting the world set focus on Shenzhen Futian!
View source version on businesswire.com: https://www.businesswire.com/news/home/20211001005355/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom